ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer https://t.co/CVSwGCnpck
792 followers
14 followers
ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer https://t.co/mmPMewLlWa https://t.co/FLUblDkhrP
511 followers
ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer https://t.co/tC8HIrfTOh https://t.co/1KaSlDubLz
906 followers
New article: ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer https://t.co/24tX6geJ9v #lungcancer #oncology https://t.co/sl93ZXNTXi